MSL
INSM icon

Mackay Shields LLC’s Insmed INSM Stock Holding History

Mackay Shields LLC’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-47,744
Closed -$1.63M – 1004
2021
Q1 		$1.63M Sell
47,744
-24,936
-34% -$953K 0.01% 846
2020
Q4 		$2.42M Sell
72,680
-17,300
-19% -$632K 0.02% 778
2020
Q3 		$2.89M Sell
89,980
-3,400
-4% -$97.7K 0.02% 628
2020
Q2 		$2.57M Buy
93,380
+16,700
+22% +$396K 0.02% 649
2020
Q1 		$1.23M Sell
76,680
-19,500
-20% -$462K 0.01% 874
2019
Q4 		$2.3M Buy
96,180
+17,600
+22% +$358K 0.02% 816
2019
Q3 		$1.39M Buy
78,580
+12,400
+19% +$239K 0.01% 1036
2019
Q2 		$1.69M Buy
66,180
+41,836
+172% +$1.17M 0.01% 966
2019
Q1 		$708K Sell
24,344
-6,400
-21% -$166K 0.01% 1096
2018
Q4 		$403K Sell
30,744
-3,264
-10% -$52.1K ﹤0.01% 1204
2018
Q3 		$688K Buy
34,008
+5,100
+18% +$115K 0.01% 953
2018
Q2 		$684K Hold
28,908
– – ﹤0.01% 1035
2018
Q1 		$651K Buy
+28,908
New +$761K ﹤0.01% 1073

Other funds holding INSM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Mackay Shields LLC's INSM Position: Q2 2021 in Review

Mackay Shields LLC sold out of Insmed (INSM) in Q2 2021, closing a stake of 47,744 shares — an estimated $1.63M sold.

Mackay Shields LLC first reported a position in INSM in Q1 2018 and held it in 13 quarters. The position peaked at $2.89M in Q3 2020. 203 funds tracked by Wall St. Rank hold INSM as of Q2 2021.

  • Mackay Shields LLC reported no remaining Insmed position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 47,744 Insmed shares in Q2 2021, an estimated $1.63M.
  • Mackay Shields LLC first reported a position in Insmed in Q1 2018 and held it in 13 quarters.
  • Mackay Shields LLC's Insmed position peaked at $2.89M in Q3 2020.
  • 203 funds tracked by Wall St. Rank held Insmed as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.